Medis 1 on 1: Sarah Bär

Medis 1 on 1: Sarah Bär

QFR® as a predictive tool for nontarget vessel-related events in STEMI patients In the interview series ‘Medis 1 on 1’, prof. Hans Reiber (CSO, Medis Medical Imaging) interviews a scientist…

Read More
Answers to the QFR Visual Interpretation Challenge

Answers to the QFR Visual Interpretation Challenge

It has been a month since we invited people to the QFR Visual Interpretation Challenge during the EuroPCR 2021. Over 400 participants participated in the QFR Visual Interpretation Challenge. Below we…

Read More
EuroPCR 2021: Reflections by Hans Reiber

EuroPCR 2021: Reflections by Hans Reiber

As Chief Scientific Officer at Medis Medical Imaging, I have participated actively in many EuroPCR meetings over the past few years. Since the introduction of QFR at the EuroPCR in…

Read More
Medis 1 on 1: Simone Biscaglia

Medis 1 on 1: Simone Biscaglia

QFR® as a predictive tool for post PCI physiology In the interview series ‘Medis 1 on 1’, prof. Hans Reiber (CSO, Medis Medical Imaging) interviews a scientist on his/her research…

Read More
Medis Suite MR Explained

Medis Suite MR Explained

Medis Suite MR is our solution for the assessment of the different structures of the heart and the heart’s function in both scientific research and in clinical routine. It comes…

Read More
Medis 1 on 1: Prof. David Leistner & Aslihan Erbay

Medis 1 on 1: Prof. David Leistner & Aslihan Erbay

QFR® as a new tool for the assessment of non-culprit lesions in ACS In the interview series ‘Medis 1 on 1’, prof. Hans Reiber (CSO, Medis Medical Imaging) interviews a…

Read More
QFR® allows for identification of lesion risk over a prolonged period of time

QFR® allows for identification of lesion risk over a prolonged period of time

QFR® identified additional lesions at risk for future nontarget vessel–related events in STEMI through 5 years of follow up. Dr Sarah Bär et al from Univ of Bern, Switzerland carried…

Read More
QFR® Quicktips 2020

QFR® Quicktips 2020

QFR® is the innovative technology allowing for the assessment of functional significant coronary lesions, without the use of adenosine and the use of pressure wires. In addition detailed anatomical information…

Read More
QFR® significantly reduces exposure to ionizing radiation during PCI

QFR® significantly reduces exposure to ionizing radiation during PCI

In a recent prospective study in 421 patients, the fluoroscopy time (FT) was measured. With QFR® the FT was only 47% of that of FFR and 30% of iFR. QFR®…

Read More
QFR® Quicktip: End Diastolic Frame Selection

QFR® Quicktip: End Diastolic Frame Selection

QFR® uses the End-Diastolic(ED) phase image to construct 3D images. As the first step ofQFR® Quicktip: End Diastolic Frame Selection QFR®, you need to select the ED phase in your…

Read More